GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aion Therapeutic Inc (XCNQ:AION) » Definitions » EBITDA Margin %

Aion Therapeutic (XCNQ:AION) EBITDA Margin % : -141.89% (As of Jan. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Aion Therapeutic EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Aion Therapeutic's EBITDA for the three months ended in Jan. 2024 was C$-0.32 Mil. Aion Therapeutic's Revenue for the three months ended in Jan. 2024 was C$0.22 Mil. Therefore, Aion Therapeutic's EBITDA margin for the quarter that ended in Jan. 2024 was -141.89%.


Aion Therapeutic EBITDA Margin % Historical Data

The historical data trend for Aion Therapeutic's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aion Therapeutic EBITDA Margin % Chart

Aion Therapeutic Annual Data
Trend Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23
EBITDA Margin %
Get a 7-Day Free Trial - - - - -

Aion Therapeutic Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -141.89

Competitive Comparison of Aion Therapeutic's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Aion Therapeutic's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aion Therapeutic's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aion Therapeutic's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Aion Therapeutic's EBITDA Margin % falls into.



Aion Therapeutic EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Aion Therapeutic's EBITDA Margin % for the fiscal year that ended in Apr. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Apr. 2023 )/Revenue (A: Apr. 2023 )
=-0.09/0
= %

Aion Therapeutic's EBITDA Margin % for the quarter that ended in Jan. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Jan. 2024 )/Revenue (Q: Jan. 2024 )
=-0.315/0.222
=-141.89 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aion Therapeutic  (XCNQ:AION) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Aion Therapeutic EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Aion Therapeutic's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Aion Therapeutic (XCNQ:AION) Business Description

Traded in Other Exchanges
Address
700 West Georgia Street, Suite 2200, Vancouver, BC, CAN, V7Y 1K8
Aion Therapeutic Inc is in the business of research and development, treatment, data mining, and state of the art artificial intelligence techniques, focused on the development of combinatorial pharmaceuticals, nutraceuticals, and cosmeceuticals utilizing compounds from cannabis, psychedelic mushrooms, fungi, natural psychedelic formulations, and other medicinal plants in a legal environment for this type of discovery.
Executives
Ismail Abdul Fattah Director or Senior Officer of 10% Security Holder

Aion Therapeutic (XCNQ:AION) Headlines

No Headlines